We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
that was a fast jump.
seems to be moving on them, low MM float one wonders.
Always thought they were MM lumping together a pile of smaller buy's to balance the books.
Two days on the trot things are looking up - bring on the news
Was in this weekend's edition, you should be able to view it on the web site but you won't learn much more that has already been posted.
when was the article dated? any chance u can share the full article?
Yes I noticed the article too. It would have been nice if we had read about it through SALV however. Still, at least things are happening now.
Jim has given a roundtable interview in the above. He has said they have "dosed their first patient...two or three weeks to results". I'm taking that as a positive as I'm a glass half full type of guy, but as the man says it's high risk high reward, just need to sneak the farm on without the wife spotting it. Lol ðŸ˜
Well that's really helpful of Jim!! What gets me is the fact that both Salvarx and Intensity presented at the Master Investor show 2016 with very upbeat presentations, suggesting clinical trials were just round the corner. I appreciate clinical trials take time and get delayed sometimes but it would be nice if the board just kept shareholders in the picture. Maybe we'll get some sort of update with interim results soon.
I had a moan about the lack of any company updates to Jim on twitter and got the response that he liked my tweet.....
I have tried to contact SALV regarding the lack of updates. The website hasn't been updated in months and doesn't even include Intensity Therapautics. Any emails I send bounce back. There does not seem to be any way to contact the management. Very poor communications with shareholders. Not impressed at all.
I think you mean 4 months
No news for three months now. What is going on??
And then hopefully celebrations, waiting fir news on human trails.
Is this share a sleeping giant or just dead?
Very true it's nice to see one of mine in the blue for a change 👍
Nice to finally see a little push back north to where this share should currently be. Its been so quiet here for news lately but there is so much potential and we must be so close now to human trials starting. Please bring us some good news soon jim
This morning, any rumours floating around? Like the look of the sequence of 10k buys, smacks of knowledge of something.
Wonder if human trials are about to start?
there is a very strong future here ... DYOR
that's right..!!! Wt else i should add..! the leadership ? about controversy...< QC & prominent barrister joined as well on BOD..!! All looks good ...
The sp may well go lower in the absence of further news but the fundamentals are sound. The current valuation is £8 million, but Salv has a number of potential blockbuster drugs in the pipeline for clinical trials, hopefully starting this year with Intensity Therapeutic's very promising insitu delivery system. Each drug has the potential to be acquired for over $1 billion by one of the big pharmas, if the clinical data supports it. Above all though Salv has a team consisting of the best in its class in the field of cancer immunotherapy and business brains backing it.
At 34p. Now i think i will but back in next month as it seems to be fluttering between 23p- 25p the reality is , this will not rise u till we start human trials and maybe buy into more companies. With good results on the himan trials , this sp will shoot up. I have no dout that if we start human trials and we dont have any share placements , this sp will one day be a winner. Its just a matter of time , i think 1-5 years personal. But i beleive it will come good at some point in the future
Looks like a buy, that's a lot of faith in a rise. I say buy because the price has not dropped.